发明名称 PHARMACEUTICAL COMPOSITION COMPRISING LIPIDS COMPRISING A POLAR AND A NONPOLAR MOIETY
摘要 The present invention provides a composition comprising (i) a lipid compound comprising at least one non-polar moiety and a polar moiety, wherein the non-polar moiety is of the formula X-Y-Z- wherein X is an acetylenic hydrocarbyl group containing a single CC bond, Y is O or CH2, and Z is an optional hydrocarbyl group, wherein the polar moiety is of the formula -[T]mPHG, wherein [T]m is an optional group selected from C(O), NH, NR1, NHC(O), C(O)NH, NR1C(O) and C(O)NR1 and CH2, where R1 is a hydrocarbyl group, wherein PHG is a polar head group, and wherein m is the number of non-polar moieties (ii) a therapeutic agent.
申请公布号 WO03011252(A1) 申请公布日期 2003.02.13
申请号 WO2002GB03488 申请日期 2002.07.29
申请人 MITSUBISHI CHEMICAL CORPORATION;FLETCHER, STEVEN;JORGENSEN, MICHAEL, R.;MILLER, ANDREW, DAVID 发明人 FLETCHER, STEVEN;JORGENSEN, MICHAEL, R.;MILLER, ANDREW, DAVID
分类号 A61K47/24;A61K9/127;A61K48/00;A61P1/00;A61P1/02;A61P1/04;A61P1/16;A61P3/00;A61P5/00;A61P7/00;A61P7/02;A61P7/04;A61P9/00;A61P9/04;A61P9/10;A61P11/02;A61P11/06;A61P13/08;A61P13/12;A61P15/00;A61P15/08;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/08;A61P19/10;A61P21/04;A61P25/00;A61P25/02;A61P25/06;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/14;A61P27/16;A61P29/00;A61P31/00;A61P31/18;A61P35/00;A61P37/02;A61P37/04;A61P37/06;A61P37/08;A61P43/00;C07C217/06;C07F9/09;(IPC1-7):A61K9/127 主分类号 A61K47/24
代理机构 代理人
主权项
地址